View Press Releases
-
Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms
Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms
Sep 16, 2025
-
Abselion Introduces Protein G Total Antibody Quantification Kit
New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform
Sep 21, 2025
-
Huateng Pharma Highlights Key Intermediate for Aficamten
Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.
Sep 21, 2025
-
Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services
Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners
Sep 15, 2025
-
Ardent Health Announces Enterprise Rollout of Ambience Healthcare's AI Platform for Documentation, Coding and Clinical Workflows
Sep 16, 2025
-
BMJ Group report reveals digital health expectation gap, with healthcare professionals left waiting for productivity gains
Sep 16, 2025
-
Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration
AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform
Sep 15, 2025
-
Sapio Sciences Introduces World’s First 3rd-Generation ELN
Sapio ELaiN is an agentic, AI–powered notebook where scientists collaborate directly with an AI co-scientist
Sep 15, 2025
-
FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium to Enable Gene Therapy Production
• First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures • Additional capabilities for continuous Adeno-Associated Virus (AAV) and Lentivirus (LV) production for consistent quality, performance, and scalability
Sep 14, 2025
-
Abzena Enhances AbZelectPRO™ Cell Line Offering with New GS Knockout Platforms
Sep 15, 2025
-
Advarra launches AI- and data-backed study design solution to improve operational efficiency in clinical trials
Sep 15, 2025
-
PubHive Named Best Scientific Literature Platform 2025 by SME News
SME News awards PubHive for transforming scientific literature workflows with AI-powered automation across life sciences.
Sep 15, 2025
-
Ketryx Secures $39M to Transform Compliance in AI-Powered MedTech
Ketryx, a Cambridge and Vienna-based compliance tech startup, raised $39 million in Series B funding led by Transformation Capital to modernize regulatory processes for AI-driven healthcare and medical device companies.
Sep 14, 2025
-
VieCure and N-Power Medicine Partner to Transform Precision Medicine and Clinical Trial Access in Community Oncology
N-Power Medicine and VieCure announced a strategic partnership that will enable more community oncology practices to incorporate cutting-edge research into patient treatment plans while delivering precision medicine insights directly at the point of care.
Sep 10, 2025
-
PRESS RELEASE: Elegen Boosts the Speed and Reliability of mRNA Synthesis with Commercial Launch of ENFINIA™ IVT Ready DNA
Sep 8, 2025
-
Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits
• Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes • Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency
Sep 8, 2025
-
Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research
Partnership delivers global, end-to-end solutions to accelerate genomics research
Sep 8, 2025
-
DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care
Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.
Sep 10, 2025
-
UMass Signed a Non-Exclusive License Agreement with Hongene
UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.
Sep 8, 2025
-
Gifthealth + Occam Health: Transforming Patient Access at Scale
Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.
Sep 4, 2025


